Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Agios Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 234
- −1 vs. Q4 2025
- Shares held
- 63.1M
- +7.41M (+13.3%) vs. Q4 2025
- Total value
- $2.12B
- +$605.4M (+40.0%) vs. Q4 2025
- New holders
- 36
- 82 more added
- Sold out
- 37
- 82 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 238 | $2.45B |
| Q1 2026 | 234 | $2.12B |
| Q4 2025 | 238 | $1.67B |
| Q3 2025 | 221 | $2.55B |
| Q2 2025 | 216 | $2.05B |
| Q1 2025 | 221 | $1.76B |
| Q4 2024 | 225 | $1.97B |
| Q3 2024 | 208 | $2.58B |
| Q2 2024 | 206 | $2.51B |
| Q1 2024 | 187 | $1.81B |
| Q4 2023 | 170 | $1.33B |
| Q3 2023 | 146 | $1.46B |
| Q2 2023 | 153 | $1.68B |
| Q1 2023 | 165 | $1.36B |
| Q4 2022 | 160 | $1.67B |
| Q3 2022 | 168 | $1.64B |
| Q2 2022 | 157 | $1.31B |
| Q1 2022 | 161 | $1.74B |
| Q4 2021 | 161 | $1.95B |
| Q3 2021 | 165 | $2.81B |
| Q2 2021 | 186 | $3.63B |
| Q1 2021 | 175 | $3.37B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Agios Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 448,118 | $15.2M | 0.02% | +94,479+26.7% | Added |
| Vestal Point Capital, LP | 450,000 | $15.2M | 0.43% | +125,000+38.5% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 450,093 | $15.2M | 0.04% | −112,549−20.0% | Reduced |
| Charles Schwab Investment Management Inc | 477,032 | $16.1M | 0.00% | −5,590−1.2% | Reduced |
| Artisan Partners Limited Partnership | 481,516 | $16.3M | 0.03% | −22,969−4.6% | Reduced |
| Bank of America Corp | 507,900 | $17.2M | 0.00% | −31,441−5.8% | Reduced |
| Northern Trust Corp | 509,272 | $17.2M | 0.00% | −2,629−0.5% | Reduced |
| Foresite Capital Management VI LLC | 525,000 | $17.8M | 3.86% | −5,000−0.9% | Reduced |
| SCS Capital Management LLC | 612,850 | $20.7M | 0.22% | +14,085+2.4% | Added |
| Citadel Advisors LLC | 619,613 | $21.0M | 0.01% | −729,355−54.1% | Reduced |
| Wellington Management Group LLP | 641,486 | $21.7M | 0.00% | +43,660+7.3% | Added |
| Jane Street Group, LLC | 685,240 | $23.2M | 0.02% | −435,810−38.9% | Reduced |
| Nuveen, LLC | 722,348 | $24.4M | 0.01% | +424,440+142.5% | Added |
| Rock Springs Capital Management LP | 799,163 | $27.0M | 1.59% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 805,776 | $27.3M | 0.00% | −228,198−22.1% | Reduced |
| Morgan Stanley | 967,525 | $32.7M | 0.00% | +73,488+8.2% | Added |
| Dimensional Fund Advisors LP | 1,151,614 | $38.9M | 0.01% | +147,273+14.7% | Added |
| GW&K Investment Management, LLC | 1,214,901 | $41.1M | 0.36% | +7,600+0.6% | Added |
| Frazier Life Sciences Management, L.P. | 1,256,080 | $42.5M | 1.09% | −23,674−1.8% | Reduced |
| MPM Oncology Impact Management LP | 1,306,261 | $44.2M | 3.41% | +2,888+0.2% | Added |
| Susquehanna International Group, LLP | 1,344,953 | $45.5M | 0.06% | +202,521+17.7% | Added |
| Geode Capital Management, LLC | 1,467,910 | $49.7M | 0.00% | +54,372+3.8% | Added |
| T. Rowe Price Investment Management, Inc. | 1,488,740 | $50.4M | 0.03% | +1,487,848+166,799.1% | Added |
| Nomura Asset Management International Inc. | 1,494,435 | $50.6M | 0.09% | −206,974−12.2% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,580,840 | $53.5M | 0.06% | +220,110+16.2% | Added |
| Erste Asset Management GmbH | 2,704,900 | $80.1M | 0.74% | −100,000−3.6% | Reduced |
| Vanguard Portfolio Management LLC | 2,611,035 | $88.3M | 0.00% | +2,611,035 | New |
| Lynx1 Capital Management LP | 2,611,568 | $88.3M | 13.96% | +2,531,944+3,179.9% | Added |
| Vanguard Capital Management LLC | 2,632,316 | $89.1M | 0.00% | +2,632,316 | New |
| D. E. Shaw & Co., Inc. | 2,681,169 | $90.7M | 0.07% | +843,983+45.9% | Added |
| Armistice Capital, LLC | 2,716,000 | $91.9M | 3.03% | −320,000−10.5% | Reduced |
| State Street Corp | 3,364,879 | $113.7M | 0.00% | +256,734+8.3% | Added |
| Farallon Capital Management, L.L.C. | 5,684,000 | $192.3M | 1.14% | +524,495+10.2% | Added |
| BlackRock, Inc. | 5,754,957 | $194.7M | 0.00% | +519,528+9.9% | Added |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −1,181,841−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −147,950−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −147,662−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −115,489−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −85,200−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −78,656−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −71,146−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −46,242−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −40,841−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −37,291−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −35,857−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −33,052−100.0% | Sold out |
| Ishara Investments LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −25,915−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −19,163−100.0% | Sold out |
| VARCOV Co. | 0 | $0 | 0.00% | −19,104−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −16,751−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,567−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −11,963−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −10,355−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −9,198−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −8,226−100.0% | Sold out |
| Griffin Asset Management, Inc. | 0 | $0 | 0.00% | −7,382−100.0% | Sold out |
| Contravisory Investment Management, Inc. | 0 | $0 | 0.00% | −6,189−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,774−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −615−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −386−100.0% | Sold out |
| Aspect Partners, LLC | 0 | $0 | 0.00% | −361−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −144−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |